会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明申请
    • THERAPEUTIC PARASITE PREPARATION AND METHODS OF MAKING AND USING
    • 治疗PARASITE制剂及其制备和使用方法
    • WO2016106332A1
    • 2016-06-30
    • PCT/US2015/067408
    • 2015-12-22
    • DONAHUE, Donald, C.
    • DONAHUE, Donald, C.
    • A61K35/62C07K14/435C12N5/07
    • A61K35/62A01K67/033A01K2227/703A01K2267/0362A01K2267/0387A61K31/7048A61K45/06A61K2300/00
    • A method of manufacturing a consumable parasitic composition includes: obtaining live parasite from an in vitro cell culture; and combining the live parasite with a consumable composition, the consumable composition having nutrients to maintain the live parasite, such as Hymenolepis diminuta cysticercoids (HDC) or Dipylidium caninum cysticercoids (DCC). The method includes obtaining cleansed Hymenolepis diminuta (HDO); incubating the HDO in cell growth media and fungi and bacteria so as to initiate fungal growth and bacterial growth; washing the HDO with antifungal and antibacterial; cracking the shells with hard beads (e.g., glass) in a swirled solution; filtering the cracked shells for removal of the shells; removing the HDC from cell culture media of the in vitro cell culture; and combining the HDC from the in vitro cell culture with the consumable composition.
    • 消耗性寄生组合物的制造方法包括:从体外细胞培养获得活体寄生虫; 并且将活体寄生虫与消耗性组合物组合,所述消耗性组合物具有营养物质以维持活体寄生虫,例如隐球菌隐球囊虫(HDC)或犬胆囊囊虫(DCC)。 该方法包括获得清洁的Hymenolepis diminuta(HDO); 在细胞生长培养基和真菌和细菌中孵育HDO以引发真菌生长和细菌生长; 用抗真菌和抗菌洗涤HDO; 用涡旋溶液中的硬珠(例如玻璃)裂化壳; 过滤破壳以去除壳; 从体外细胞培养的细胞培养基中除去HDC; 并将来自体外细胞培养物的HDC与消耗性组合物组合。
    • 78. 发明申请
    • COMPUTER VISION BASED METHOD FOR EXTRACTING FEATURES RELATING TO THE DEVELOPMENTAL STAGE OF TRICHURIS SPP. EGGS
    • 提取与TRICHURIS SPP发展阶段相关的特征的基于计算机视觉的方法。 蛋
    • WO2013159856A1
    • 2013-10-31
    • PCT/EP2013/000855
    • 2013-03-21
    • PARASITE TECHNOLOGIES A/SBRUUN, Johan MusaeusCARSTENSEN, Jens MichaelMOLIIN OUTZEN KAPEL, Christiian
    • BRUUN, Johan MusaeusCARSTENSEN, Jens MichaelMOLIIN OUTZEN KAPEL, Christiian
    • G06K9/00A61K35/62
    • G06T7/0012A61K35/62G06K9/00147
    • There is provided a computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs, wherein for the final developmental stages a larva is present inside the egg, said Trichuris spp. eggs having a substantially oblong or elliptical shape with a protruding polar plug at each end, the shape of the Trichuris spp. eggs thereby defining a longitudinal direction and a transverse direction of the eggs. The method comprises a step of obtaining and storing one or more digital images of Trichuris spp. eggs suspended in a liquid solution, a step of detecting one or more Trichuris spp. eggs in the image(s), and a step of extracting one or more features from an egg content image region representing at least part of the egg contents of a detected egg. The extraction of one or more features from the egg content image region may include one or more measurements of the direction-dependent structures of the egg contents, such as one or more measurements of the longitudinal structures of the egg contents and/or one or more measurements of the transverse structures of the egg contents. The Trichuris spp. eggs may be Trichuris suis eggs.
    • 提供了一种基于计算机视觉的方法,用于提取与Trichuris spp的发育阶段相关的特征。 鸡蛋,其中对于最终发育阶段,幼虫存在于鸡蛋内,Trichuris spp。 具有大致长方形或椭圆形的卵,其每端具有突出的极性塞子,Trichuris spp的形状。 鸡蛋因此限定了鸡蛋的纵向和横向。 该方法包括获取并存储一种或多种Tr is属数字图像的步骤。 悬浮在液体溶液中的蛋,检测一种或多种Trichuris spp的步骤。 图像中的蛋,以及从表示检测到的蛋的蛋内容物的至少一部分的蛋内容图像区域提取一个或多个特征的步骤。 从蛋内容图像区域提取一个或多个特征可以包括蛋内容物的方向依赖结构的一个或多个测量,例如蛋内容物的纵向结构的一个或多个测量值和/或一个或多个 鸡蛋含量横向结构的测量。 Trichuris spp。 鸡蛋可能是Trichuris suis鸡蛋。
    • 79. 发明申请
    • METHODS OF TREATING FATTY LIVER DISEASE WITH HELMINTH-DERIVED GLYCAN-CONTAINING COMPOUNDS
    • 来自海因衍生的含甘氨酸化合物治疗脂肪肝疾病的方法
    • WO2013044044A2
    • 2013-03-28
    • PCT/US2012056595
    • 2012-09-21
    • HARVARD COLLEGE
    • LEE CHIH-HAOBHARGAVA PRERNAHARN DONALD A
    • A61K48/00A61K31/726A61K38/16A61K38/17A61P1/00A61P1/16
    • A61K31/726A61K35/62A61K47/61A61K47/64
    • The present invention provides a compound comprising a helminth-derived glycan and/or glycoconjugate thereof (e.g., a compound comprising a Lewisx antigen (e.g., LNFPIII), a non-Lewisx antigen (e.g., LNnT, LDN, and LDN derivatives), or a mixture of Lewisx and non-Lewisx antigens (e.g., SEA)), useful as a therapeutic compound for treating or preventing diseases associated with fat accumulation in the liver. The compounds of the invention are useful for treating or preventing the development of a fatty liver disease in a subject that has the disease or is at risk of developing the disease, and inhibiting lipogenesis in hepatocytes. The invention also provides methods of regulating the Erk-c-fos/AP-1-FXRalpha signalling pathway by administering a compound comprising a helminth-derived glycan and/or glycoconjugate thereof to a subject with a fatty liver disease, or contacting a hepatocyte with a compound comprising a helminth-derived glycan and/or glycoconjugate thereof.
    • 本发明提供了包含蠕虫衍生的聚糖和/或其糖缀合物(例如,包含Lewisx抗原(例如LNFPIII),非Lewisx抗原(例如LNnT,LDN和LDN衍生物)的化合物)或 Lewisx和非Lewisx抗原(例如SEA)的混合物),其用作治疗或预防与肝脏中的脂肪积聚相关的疾病的治疗性化合物。 本发明化合物可用于治疗或预防患有该疾病或处于发展疾病风险中的受试者的脂肪肝疾病的发展,并抑制肝细胞中的脂肪生成。 本发明还提供了通过向患有脂肪肝疾病的受试者施用包含蠕虫衍生的聚糖和/或其糖缀合物的化合物或使肝细胞与脂肪肝病患者接触来调节Erk-c-fos / AP-1-FXRα信号传导途径的方法 包含其蠕虫衍生的聚糖和/或其糖缀合物的化合物。